Form 4: Hinge Health Director Sells Shares
Insider Transaction (Form 4)
Gabriel M.I. Mecklenburg, a Director of Hinge Health, Inc., sold 150,000 shares of common stock on September 14, 2026.
Summary
- Conversion of derivative: acquired 150,000 Class A Common Stock on September 14, 2026; holds 150,000 after (Direct).
- Open-market sale: disposed of 2,800 Class A Common Stock at $88.98 ($249,142) on September 14, 2026; holds 147,200 after (Direct).
- Open-market sale: disposed of 11,700 Class A Common Stock at $91.09 ($1,065,781) on September 14, 2026; holds 135,500 after (Direct).
- Open-market sale: disposed of 16,540 Class A Common Stock at $91.92 ($1,520,352) on September 14, 2026; holds 118,960 after (Direct).
- Open-market sale: disposed of 56,161 Class A Common Stock at $93.00 ($5,222,732) on September 14, 2026; holds 62,799 after (Direct).
- Open-market sale: disposed of 33,501 Class A Common Stock at $94.03 ($3,150,186) on September 14, 2026; holds 29,298 after (Direct).
- Open-market sale: disposed of 29,298 Class A Common Stock at $94.70 ($2,774,617) on September 14, 2026 (Direct).
- Conversion of derivative: disposed of 150,000 Class B Common Stock on September 14, 2026; holds 1,844,004 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $13,982,810 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Gabriel M.I. Mecklenburg — Director, Other (Exec. Chairman & Co-Founder)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-14 | Conversion of derivative | Class A Common Stock | 150,000 | — | — | 150,000 |
| 2026-09-14 | Open-market sale | Class A Common Stock | 2,800 | $89 | $249.1K | 147,200 |
| 2026-09-14 | Open-market sale | Class A Common Stock | 11,700 | $91 | $1.1M | 135,500 |
| 2026-09-14 | Open-market sale | Class A Common Stock | 16,540 | $92 | $1.5M | 118,960 |
| 2026-09-14 | Open-market sale | Class A Common Stock | 56,161 | $93 | $5.2M | 62,799 |
| 2026-09-14 | Open-market sale | Class A Common Stock | 33,501 | $94 | $3.2M | 29,298 |
| 2026-09-14 | Open-market sale | Class A Common Stock | 29,298 | $95 | $2.8M | 0 |
| 2026-09-14 | Conversion of derivative | Class B Common Stock | 150,000 | — | — | 1,844,004 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-14 | Conversion of derivative (150,000 shares) |
| 2026-09-14 | Open-market sale (2,800 shares) |
| 2026-09-14 | Open-market sale (11,700 shares) |
| 2026-09-14 | Open-market sale (16,540 shares) |
| 2026-09-14 | Open-market sale (56,161 shares) |
| 2026-09-14 | Open-market sale (33,501 shares) |
| 2026-09-14 | Open-market sale (29,298 shares) |
| 2026-09-14 | Conversion of derivative (150,000 shares) |
Keywords
insider transaction, Form 4, HNGE, Hinge Health, Inc., bearish, Gabriel M.I. Mecklenburg
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.